Although the blood brain barrier was thought classically to block the entry of immune cells into the brain under normal conditions, more recent work from this laboratory and others suggests that activated lymphocytes, particularly CD4 Th1 cells, can enter the brain in the absence of an inflammatory focus. This migratory pathway is important not only in normal immune surveillance of non-lymphoid organs but also in the initiation of tissue-specific autoimmune disease. However, the molecular mediators that regulate this early """"""""blundering"""""""" of lymphocytes into the brain remain unclear. An additional unanswered question is whether immune surveillance is tissue specific or requires the same molecular steps in all non-lymphoid tissues. We hypothesize that the entry of these """"""""pioneer"""""""" lymphocytes into the brain is regulated by a set of molecular events that are distinct from those used once inflammation has been established. Preliminary work using an in vivo assay system supports this hypothesis and demonstrates that early migration occurs independent of the lymphocyte integrin very late antigen 4 (VLA-4) and endothelial vascular cell adhesion molecule (VCAM) but does require increased surface expression of endothelial P selectin.
The specific aims of this project are first to determine the role of known adhesion molecules in the early migration of Th1 cells into the brain as compared to another immune privileged organ, the pancreas; second to compare migration of Th1 cells to the steps required for Th2 and CD8 lymphocytes; third to examine in more detail the role of P selectin and its regulation by early migrating cells; and fourth to determine the modulation of a mouse model of autoimmune disease, experimental autoimmune encephalitis (EAE), by early migrating Th1 cells. This work will provide improved understanding of in vivo immune cell migration and may suggest new treatment strategies for inflammatory disorders of the central nervous system such as multiple sclerosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08NS002124-01
Application #
2901740
Study Section
NST-2 Subcommittee (NST)
Program Officer
Kerza-Kwiatecki, a P
Project Start
1999-07-05
Project End
2002-06-30
Budget Start
1999-07-05
Budget End
2000-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Yale University
Department
Neurology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Carrithers, Michael; Tandon, Suman; Canosa, Sandra et al. (2005) Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol 166:185-96
Carrithers, Michael D; Visintin, Irene; Viret, Christophe et al. (2002) Role of genetic background in P selectin-dependent immune surveillance of the central nervous system. J Neuroimmunol 129:51-7
Carrithers, M D; Visintin, I; Kang, S J et al. (2000) Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 123 ( Pt 6):1092-101
Nadon, N L; Duncan, I D (1995) Gene expression and oligodendrocyte development in the myelin deficient rat. J Neurosci Res 41:96-104